The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Skin Cancers MORE >>

Pembrolizumab has been granted an accelerated approval by the FDA as a treatment for adult and pediatric patients with recurrent locally advanced or metastatic Merkel cell carcinoma.

Latest JournalAll Journals >>

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.